Elite members get real-time data, technical charting, alerts, and no ads - starting at $24.96/mo.
Try Elite for Free
Last Close
0.4740
Nov 06 • 3:59 PM ET Dollar change-0.0460 Percentage change(-8.85%)
Aftermarket Close
0.4998
Aftermarket • 7:30 PM ET Dollar change+0.0258 Percentage change(5.44%)
Nov 05, 3:49 AMeHealth reaffirms 2026 guidance as Q3 loss widens, cash flow improves despite 64% Medicare revenue and 58% MA application declines
Index
-
Market Cap
15.19M
Enterprise Value
477.84M
Income
-32.09M
Sales
469.10M
Book/sh
15.29
Cash/sh
2.75
Dividend Est.
-
Dividend TTM
-
Dividend Ex-Date
-
Dividend Gr. 3/5Y
- -
Payout
-
Employees
1665
IPO
Oct 13, 2006
P/E
-
Forward P/E
0.40
PEG
-
P/S
0.03
P/B
0.03
P/C
0.17
P/FCF
-
EV/EBITDA
6.91
EV/Sales
1.02
Quick Ratio
8.68
Current Ratio
8.68
Debt/Eq
0.14
LT Debt/Eq
0.14
Option/Short
Yes / Yes
EPS (ttm)
-1.02
EPS next Y
1.20
EPS next Q
2.69
EPS this Y
-28.24%
EPS next Y
-10.89%
EPS next 5Y
-16.73%
EPS past 3/5Y
57.24% -
Sales past 3/5Y
10.98% -1.01%
EPS Y/Y TTM
-899.66%
Sales Y/Y TTM
-13.60%
EPS Q/Q
-7.79%
Sales Q/Q
-60.49%
Insider Own
11.71%
Insider Trans
-2.98%
Inst Own
49.28%
Inst Trans
-6.51%
ROA
2.12%
ROE
2.55%
ROIC
2.21%
Gross Margin
-
Oper. Margin
11.94%
Profit Margin
-6.84%
SMA20
-15.94%
SMA50
-35.72%
SMA200
-66.64%
Trades
Shs Outstand
32.28M
Shs Float
28.28M
52W High
5.35 -91.14%
52W Low
0.45 4.43%
Volatility
20.48% 10.37%
ATR (14)
0.07
RSI (14)
34.74
Beta
1.54
Rel Volume
1.61
Avg Volume
389.91K
Volume
626,838
Perf Week
-3.68%
Perf Month
-33.13%
Perf Quarter
-62.38%
Perf Half Y
-74.92%
Perf YTD
-89.70%
Perf Year
-87.72%
Perf 3Y
-94.37%
Perf 5Y
-98.83%
Perf 10Y
-94.06%
Prev Close
0.52
Price
0.47
Change %
-8.85%
Consensus
Hold
Avg. Price Target
$1.58
Implied Upside
+233.3%
Analysts11incl. previous ratings
Rating Distribution0 Buy · 11 Hold · 0 Sell
DateActionAnalystRating ChangePrice Target ChangeImplied Upside
Feb 26, 2026Downgrade
CCraig Hallum
Buy → Hold$2+321.9%
Dec 04, 2024Initiated
UBS logoUUBS
Neutral$5.50+1,060.3%
Jan 18, 2024Downgrade
CCraig Hallum
Buy → Hold$7+1,376.8%
Dec 01, 2022Upgrade
CCraig Hallum
Hold → Buy$6+1,165.8%
Apr 01, 2022Resumed
CCredit Suisse
Neutral$16+3,275.5%
Mar 21, 2022Downgrade
C logoCCitigroup
Buy → Neutral$37 → $15+3,064.6%
Mar 02, 2022Downgrade
TFC logoTTruist
Buy → Hold
Mar 02, 2022Downgrade
EVR logoEEvercore ISI
Outperform → In-line
Jan 18, 2022Downgrade
BCS logoBBarclays
Overweight → Equal Weight$22+4,541.4%
Jan 07, 2022Downgrade
CCredit Suisse
Outperform → Neutral$45 → $31+6,440.1%
Insider Trading Relationship Date Transaction Cost #Shares Value ($) #Shares Total SEC Form 4
SOISTMAN FRANCIS S JRDirectorOct 01 '26Sale0.7020,30614,137994,915Oct 02 06:49 PM
SOISTMAN FRANCIS S JRDirectorOct 02 '26Sale0.6920,30614,038974,609Oct 02 06:49 PM
FRANCIS S. SOISTMANDirectorOct 02 '26Proposed Sale0.6920,30614,038Oct 02 04:02 PM
FRANCIS S. SOISTMAN JR.DirectorOct 01 '26Proposed Sale0.7020,30614,137Oct 01 04:09 PM
SOISTMAN FRANCIS S JRDirectorAug 31 '26Sale1.1437,29642,4321,052,518Sep 02 04:19 PM
SOISTMAN FRANCIS S JRDirectorSep 01 '26Sale1.0537,29739,2771,015,221Sep 02 04:19 PM
FRANCIS S. SOISTMAN JR.DirectorSep 01 '26Proposed Sale1.0537,29739,277Sep 01 04:20 PM
FRANCIS S. SOISTMAN JR.DirectorAug 31 '26Proposed Sale1.1437,29642,432Aug 31 04:42 PM
Dolan John JosephChief Financial OfficerMar 06 '26Buy1.5325,00038,190208,755Mar 09 04:03 PM
DUKE DERRICK AChief Executive OfficerFeb 27 '26Buy1.38187,969259,397487,969Mar 02 04:13 PM
eHealth, Inc. engages in the provision of internet-based health insurance agency services for individuals, families, and small businesses. It operates through the following segments: Medicare and Employer and Individual (E&I). The Medicare segment consists primarily of commissions earned from sale of Medicare-related health insurance plans. The E&I segment includes commissions earned from the sale of individual and family and small business health insurance plans and ancillary products sold to non-Medicare-eligible customers. The company was founded by Vipool Mohanlal Patel in November 1997 and is headquartered in Indianapolis, IN.
CEO & DirectorMr. Derrick Anthony Duke C.F.A.
Senior VP & CFOMr. John Joseph Dolan
Senior VP & Chief Revenue OfficerMs. Michelle M. Barbeau
Senior Vice President of Investor Relations & Corporate DevelopmentMs. Kate Sidorovich CFA
Senior VPMr. Gavin Guy Galimi